Validación de biomarcadores plasmáticos para la detección temprana y específica de la enfermedad de Alzheimer y evaluación pronóstica a 2 años.

Datos básicos

Código:
CNS2022-135327
Protocolo:
CNS2022-135327
EUDRACT:
NCT:
Centro:
Dotación:
182.895,00 €
Año de incio:
2023
Año de finalización:
2025
PI BIOMÉDICA NACIONAL Finan. Competitiva Pública

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

MINISTERIO DE CIENCIA E INNOVACION

Resultados del Ensayo Clínico


Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.1007/s00415-023-11899-5. 2023


Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.

Garcia-Lluch, Gemma; (...); Chafer-Pericas, Consuelo

Article. 10.1177/13872877241304995. 2024


Author Correction: Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease.

Ferré-González L; (...); Cháfer-Pericás C

Correction. 10.1038/s41598-024-52528-z. 2024


Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease

Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo

Article. 10.1038/s41598-024-51463-3. 2024


Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions.

García-Lluch G; (...); Cháfer-Pericás C

Article. 10.14283/jpad.2024.16. 2024


Defining Alzheimer's Disease through Proteomic CSF Profiling.

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.1021/acs.jproteome.4c00590. 2024


Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers

Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo

Article. 10.3390/ijms241814151. 2023


Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment.

Álvarez-Sánchez L; (...); Pericás CC

Article. 10.2174/011570159X332930240925095423. 2024


Influence of Statin Potency and Liposolubility on Alzheimer's disease patients: a population-based study.

Garcia-Zamora, Mar; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.phrs.2024.107446. 2024


Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation.

Baquero, Miguel; (...); Chafer-Pericas, Consuelo

Article. 10.3390/jcm13164735. 2024


New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers.

Forte, Anabel; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.cca.2024.117842. 2024


Plasma lipidomics in early APP/PS1 female mouse model and its relationship with brain: Is it affected by the estrous cycle?

Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo

Article. 10.1186/s13195-024-01549-x. 2024


Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.

Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis

Article. 10.1016/j.bbr.2023.114844. 2024


Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease.

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.3390/ijms25105317. 2024


Response to letter to the editor: An in-depth look at the relationship between anti-diabetic drugs and Alzheimer's disease.

Garcia-Zamora, Mar; (...); Pardo Albiach, Juan

Letter. 10.1016/j.phrs.2024.107396. 2024


Response to letter to the editor: Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer's disease management.

Garcia-Zamora, Mar; (...); Pardo, Juan

Letter. 10.1016/j.phrs.2025.107595. 2025


Campos de estudio

Compartir